BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 270770)

  • 1. The electronic and serotonin receptor binding affinity properties of N,N-dimethyltryptamine analogs.
    Glennon RA; Gessner PK
    Res Commun Chem Pathol Pharmacol; 1977 Nov; 18(3):453-65. PubMed ID: 270770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationships for hallucinogenic N,N-dialkyltryptamines: photoelectron spectra and serotonin receptor affinities of methylthio and methylenedioxy derivatives.
    Kline TB; Benington F; Morin RD; Beaton JM; Glennon RA; Domelsmith LN; Houk KN; Rozeboom MD
    J Med Chem; 1982 Nov; 25(11):1381-3. PubMed ID: 6815326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on several 7-substituted N,N-dimethyltryptamines.
    Glennon RA; Schubert E; Jacyno JM; Rosecrans JA
    J Med Chem; 1980 Nov; 23(11):1222-6. PubMed ID: 6779006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin receptor binding affinities of several hallucinogenic phenylalkylamine and N,N-dimethyltryptamine analogues.
    Glennon RA; Liebowitz SM; Mack EC
    J Med Chem; 1978 Aug; 21(8):822-5. PubMed ID: 278843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for and against the involvement of N,N-dimethyl-tryptamine (DMT) and 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in schizophrenia.
    Gillin JC; Wyatt RJ
    Psychopharmacol Bull; 1976 Oct; 12(4):12-3. PubMed ID: 1067623
    [No Abstract]   [Full Text] [Related]  

  • 6. A quantum chemical investigation of the pi-electronic structure of the hallucinogenic N,N-dimethyltryptamines.
    Glennon RA
    Res Commun Chem Pathol Pharmacol; 1974 Sep; 9(1):185-8. PubMed ID: 4531086
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis and serotonin receptor affinities of a series of enantiomers of alpha-methyltryptamines: evidence for the binding conformation of tryptamines at serotonin 5-HT1B receptors.
    Nichols DE; Lloyd DH; Johnson MP; Hoffman AJ
    J Med Chem; 1988 Jul; 31(7):1406-12. PubMed ID: 3385733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo metabolism of 5-methoxy-N,N-dimethyltryptamine and N,N-dimethyltryptamine in the rat.
    Sitaram BR; Lockett L; Talomsin R; Blackman GL; McLeod WR
    Biochem Pharmacol; 1987 May; 36(9):1509-12. PubMed ID: 3472526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative selectivity of some conformationally constrained tryptamine analogs at 5-HT1, 5-HT1A and 5-HT2 recognition sites.
    Taylor EW; Nikam S; Weck B; Martin A; Nelson D
    Life Sci; 1987 Oct; 41(16):1961-9. PubMed ID: 3657392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of metabolism of psychotomimetic indolealkylamines by rat tissue extracts using liquid chromatography.
    Sitaram BR; Talomsin R; Blackman GL; McLeod WR
    Biochem Pharmacol; 1987 May; 36(9):1503-8. PubMed ID: 3472525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin autoreceptors on dorsal raphe neurons: structure-activity relationships of tryptamine analogs.
    Rogawski MA; Aghajanian GK
    J Neurosci; 1981 Oct; 1(10):1148-54. PubMed ID: 6793698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of some biochemical abnormalities in schizophrenia.
    Rodnight R
    Acta Neurol (Napoli); 1975; 30(1):85-101. PubMed ID: 1063539
    [No Abstract]   [Full Text] [Related]  

  • 13. [Receptor affinity of ecliptic fixed tryptamine and serotonin analogs].
    Rehse K; Peetsch R; Kehr W
    Arch Pharm (Weinheim); 1987 Oct; 320(10):1072-83. PubMed ID: 3435231
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular orbital studies on the conformation of hallucinogenic indolealkylamines and related compounds. The isolated molecules and the solvent effect.
    Pullman B; Courrière P; Berthod H
    J Med Chem; 1974 Apr; 17(4):439-47. PubMed ID: 4524607
    [No Abstract]   [Full Text] [Related]  

  • 15. Further studies on the binding of N1-substituted tryptamines at h5-HT6 receptors.
    Nyandege A; Kolanos R; Roth BL; Glennon RA
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1691-4. PubMed ID: 17239595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of a novel series of N,N-dimethylisotryptamines.
    Glennon RA; Jacyno JM; Young R; McKenney JD; Nelson D
    J Med Chem; 1984 Jan; 27(1):41-5. PubMed ID: 6581313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2,3-dihydro and carbocyclic analogues of tryptamines: interaction with serotonin receptors.
    Glennon RA; Jacyno JM; Salley JJ
    J Med Chem; 1982 Jan; 25(1):68-70. PubMed ID: 7086824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of isotryptamines and indenes at h5-HT6 serotonin receptors.
    Kolanos R; Siripurapu U; Pullagurla M; Riaz M; Setola V; Roth BL; Dukat M; Glennon RA
    Bioorg Med Chem Lett; 2005 Apr; 15(8):1987-91. PubMed ID: 15808453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in vitro identification of dimethyltryptamine (DMT) in mammalian brain and its characterization as a possible endogenous neuroregulatory agent.
    Christian ST; Harrison R; Quayle E; Pagel J; Monti J
    Biochem Med; 1977 Oct; 18(2):164-83. PubMed ID: 20877
    [No Abstract]   [Full Text] [Related]  

  • 20. N, N-dimethyltryptamine: an endogenous hallucinogen.
    Barker SA; Monti JA; Christian ST
    Int Rev Neurobiol; 1981; 22():83-110. PubMed ID: 6792104
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.